{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:21:47Z","timestamp":1774383707621,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T00:00:00Z","timestamp":1558224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T00:00:00Z","timestamp":1558224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG061114"],"award-info":[{"award-number":["R01AG061114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG053876"],"award-info":[{"award-number":["R21AG053876"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG061715"],"award-info":[{"award-number":["R21AG061715"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS096642"],"award-info":[{"award-number":["R21NS096642"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008522","name":"University of Illinois at Chicago","doi-asserted-by":"crossref","award":["Instutional Start-Up Funds"],"award-info":[{"award-number":["Instutional Start-Up Funds"]}],"id":[{"id":"10.13039\/100008522","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["#A-11014"],"award-info":[{"award-number":["#A-11014"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["#A-11014"],"award-info":[{"award-number":["#A-11014"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12035-019-1634-y","type":"journal-article","created":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T16:41:12Z","timestamp":1558284072000},"page":"7708-7718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["EGF Treatment Improves Motor Behavior and Cortical GABAergic Function in the R6\/2 Mouse Model of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"56","author":[{"given":"Felecia M.","family":"Marottoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Priego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eden","family":"Flores-Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Pisharody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Zaldua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly D.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giri K.","family":"Ekkurthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott T.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo A.","family":"Morfini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuei Y.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4430-6717","authenticated-orcid":false,"given":"Leon M.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,19]]},"reference":[{"issue":"5940","key":"1634_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K et al (1983) A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306(5940):234\u2013238","journal-title":"Nature"},{"issue":"5","key":"1634_CR2","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","volume":"113","author":"I Han","year":"2010","unstructured":"Han I, You Y, Kordower JH, Brady ST, Morfini GA (2010) Differential vulnerability of neurons in Huntington\u2019s disease: the role of cell type-specific features. J Neurochem 113(5):1073\u20131091. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06672.x","journal-title":"J Neurochem"},{"key":"1634_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-4419-6448-9_5","volume":"685","author":"E Roze","year":"2010","unstructured":"Roze E, Bonnet C, Betuing S, Caboche J (2010) Huntington\u2019s disease. Adv Exp Med Biol 685:45\u201363","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"1634_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/bies.201100116","volume":"34","author":"L Bodai","year":"2012","unstructured":"Bodai L, Marsh JL (2012) A novel target for Huntington\u2019s disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology. Bioessays 34(2):142\u2013148","journal-title":"Bioessays"},{"issue":"8","key":"1634_CR5","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.1074\/jbc.M110338200","volume":"277","author":"C Song","year":"2002","unstructured":"Song C, Perides G, Liu YF (2002) Expression of full-length polyglutamine-expanded huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells. J Biol Chem 277(8):6703\u20136707. \n                    https:\/\/doi.org\/10.1074\/jbc.M110338200","journal-title":"J Biol Chem"},{"issue":"1","key":"1634_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbadis.2012.09.001","volume":"1832","author":"MA Melone","year":"2013","unstructured":"Melone MA, Calarco A, Petillo O, Margarucci S, Colucci-D'Amato L, Galderisi U, Koverech G, Peluso G (2013) Mutant huntingtin regulates EGF receptor fate in non-neuronal cells lacking wild-type protein. Biochim Biophys Acta 1832(1):105\u2013113. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2012.09.001","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"1634_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/hmg\/ddi067","volume":"14","author":"JC Lievens","year":"2005","unstructured":"Lievens JC, Rival T, Iche M, Chneiweiss H, Birman S (2005) Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum Mol Genet 14(5):713\u2013724. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddi067","journal-title":"Hum Mol Genet"},{"key":"1634_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","volume":"250","author":"CY Lin","year":"2013","unstructured":"Lin CY, Hsu YH, Lin MH, Yang TH, Chen HM, Chen YC, Hsiao HY, Chen CC et al (2013) Neurovascular abnormalities in humans and mice with Huntington\u2019s disease. Exp Neurol 250:20\u201330. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2013.08.019","journal-title":"Exp Neurol"},{"key":"1634_CR9","doi-asserted-by":"publisher","first-page":"41316","DOI":"10.1038\/srep41316","volume":"7","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo A, Amico E, Scalabri F, Pepe G, Castaldo S, Elifani F, Capocci L, De Sanctis C et al (2017) Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington disease. Sci Rep 7:41316. \n                    https:\/\/doi.org\/10.1038\/srep41316","journal-title":"Sci Rep"},{"issue":"2","key":"1634_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.24428","volume":"78","author":"HY Hsiao","year":"2015","unstructured":"Hsiao HY, Chen YC, Huang CH, Chen CC, Hsu YH, Chen HM, Chiu FL, Kuo HC et al (2015) Aberrant astrocytes impair vascular reactivity in Huntington disease. Ann Neurol 78(2):178\u2013192. \n                    https:\/\/doi.org\/10.1002\/ana.24428","journal-title":"Ann Neurol"},{"key":"1634_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fncir.2013.00019","volume":"7","author":"AM Estrada-Sanchez","year":"2013","unstructured":"Estrada-Sanchez AM, Rebec GV (2013) Role of cerebral cortex in the neuropathology of Huntington\u2019s disease. Front Neural Circuits 7:19. \n                    https:\/\/doi.org\/10.3389\/fncir.2013.00019","journal-title":"Front Neural Circuits"},{"key":"1634_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuroscience.2015.07.021","volume":"304","author":"Y Tang","year":"2015","unstructured":"Tang Y, Ye M, Du Y, Qiu X, Lv X, Yang W, Luo J (2015) EGFR signaling upregulates surface expression of the GluN2B-containing NMDA receptor and contributes to long-term potentiation in the hippocampus. Neuroscience 304:109\u2013121. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2015.07.021","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"1634_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/0006-8993(89)90380-6","volume":"484","author":"H Terlau","year":"1989","unstructured":"Terlau H, Seifert W (1989) Influence of epidermal growth factor on long-term potentiation in the hippocampal slice. Brain Res 484(1\u20132):352\u2013356","journal-title":"Brain Res"},{"issue":"4","key":"1634_CR14","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.neuroscience.2008.10.057","volume":"158","author":"H Namba","year":"2009","unstructured":"Namba H, Zheng Y, Abe Y, Nawa H (2009) Epidermal growth factor administered in the periphery influences excitatory synaptic inputs onto midbrain dopaminergic neurons in postnatal mice. Neuroscience 158(4):1731\u20131741. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2008.10.057","journal-title":"Neuroscience"},{"issue":"1","key":"1634_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0006-8993(92)91433-F","volume":"587","author":"K Abe","year":"1992","unstructured":"Abe K, Saito H (1992) Epidermal growth factor selectively enhances NMDA receptor-mediated increase of intracellular Ca2+ concentration in rat hippocampal neurons. Brain Res 587(1):102\u2013108","journal-title":"Brain Res"},{"issue":"5","key":"1634_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10519-005-5357-7","volume":"35","author":"M Tohmi","year":"2005","unstructured":"Tohmi M, Tsuda N, Mizuno M, Takei N, Frankland PW, Nawa H (2005) Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains. Behav Genet 35(5):615\u2013629. \n                    https:\/\/doi.org\/10.1007\/s10519-005-5357-7","journal-title":"Behav Genet"},{"issue":"1","key":"1634_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.mp.4001138","volume":"8","author":"T Futamura","year":"2003","unstructured":"Futamura T, Kakita A, Tohmi M, Sotoyama H, Takahashi H, Nawa H (2003) Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol Psychiatry 8(1):19\u201329. \n                    https:\/\/doi.org\/10.1038\/sj.mp.4001138","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1634_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1460-9568.2007.05297.x","volume":"25","author":"T Nagano","year":"2007","unstructured":"Nagano T, Namba H, Abe Y, Aoki H, Takei N, Nawa H (2007) In vivo administration of epidermal growth factor and its homologue attenuates developmental maturation of functional excitatory synapses in cortical GABAergic neurons. Eur J Neurosci 25(2):380\u2013390. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05297.x","journal-title":"Eur J Neurosci"},{"key":"1634_CR19","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/jnc.14097","volume":"142","author":"H Namba","year":"2017","unstructured":"Namba H, Nagano T, Jodo E, Eifuku S, Horie M, Takebayashi H, Iwakura Y, Sotoyama H et al (2017) Epidermal growth factor signals attenuate phenotypic and functional development of neocortical GABA neurons. J Neurochem 142:886\u2013900. \n                    https:\/\/doi.org\/10.1111\/jnc.14097","journal-title":"J Neurochem"},{"issue":"4","key":"1634_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jnc.12223","volume":"126","author":"H Sotoyama","year":"2013","unstructured":"Sotoyama H, Namba H, Chiken S, Nambu A, Nawa H (2013) Exposure to the cytokine EGF leads to abnormal hyperactivity of pallidal GABA neurons: implications for schizophrenia and its modeling. J Neurochem 126(4):518\u2013528. \n                    https:\/\/doi.org\/10.1111\/jnc.12223","journal-title":"J Neurochem"},{"issue":"4","key":"1634_CR21","doi-asserted-by":"publisher","first-page":"e60012","DOI":"10.1371\/journal.pone.0060012","volume":"8","author":"I Rattray","year":"2013","unstructured":"Rattray I, Smith E, Gale R, Matsumoto K, Bates GP, Modo M (2013) Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD. PLoS One 8(4):e60012. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0060012","journal-title":"PLoS One"},{"issue":"6","key":"1634_CR22","doi-asserted-by":"publisher","first-page":"e00319","DOI":"10.1016\/j.heliyon.2017.e00319","volume":"3","author":"R Thomas","year":"2017","unstructured":"Thomas R, Morris AWJ, Tai LM (2017) Epidermal growth factor prevents APOE4-induced cognitive and cerebrovascular deficits in female mice. Heliyon 3(6):e00319. \n                    https:\/\/doi.org\/10.1016\/j.heliyon.2017.e00319","journal-title":"Heliyon"},{"issue":"1","key":"1634_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s40478-016-0387-3","volume":"4","author":"R Thomas","year":"2016","unstructured":"Thomas R, Zuchowska P, Morris AW, Marottoli FM, Sunny S, Deaton R, Gann PH, Tai LM (2016) Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice. Acta Neuropathol Commun 4(1):111. \n                    https:\/\/doi.org\/10.1186\/s40478-016-0387-3","journal-title":"Acta Neuropathol Commun"},{"issue":"18","key":"1634_CR24","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1093\/hmg\/ddv248","volume":"24","author":"RG Gatto","year":"2015","unstructured":"Gatto RG, Chu Y, Ye AQ, Price SD, Tavassoli E, Buenaventura A, Brady ST, Magin RL et al (2015) Analysis of YFP(J16)-R6\/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington\u2019s disease. Hum Mol Genet 24(18):5285\u20135298. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddv248","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1634_CR25","doi-asserted-by":"publisher","first-page":"175909141771920","DOI":"10.1177\/1759091417719201","volume":"9","author":"Felecia M. Marottoli","year":"2017","unstructured":"Marottoli FM, Katsumata Y, Koster KP, Thomas R, Fardo DW, Tai LM (2017) Peripheral inflammation, apolipoprotein E4, and amyloid-beta interact to induce cognitive and cerebrovascular dysfunction. ASN Neuro 9 (4):1759091417719201. doi:\n                    https:\/\/doi.org\/10.1177\/1759091417719201","journal-title":"ASN Neuro"},{"issue":"5","key":"1634_CR26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/mp.2014.14","volume":"19","author":"DK Cass","year":"2014","unstructured":"Cass DK, Flores-Barrera E, Thomases DR, Vital WF, Caballero A, Tseng KY (2014) CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex. Mol Psychiatry 19(5):536\u2013543. \n                    https:\/\/doi.org\/10.1038\/mp.2014.14","journal-title":"Mol Psychiatry"},{"issue":"33","key":"1634_CR27","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.1523\/JNEUROSCI.0932-17.2017","volume":"37","author":"E Flores-Barrera","year":"2017","unstructured":"Flores-Barrera E, Thomases DR, Cass DK, Bhandari A, Schwarcz R, Bruno JP, Tseng KY (2017) Preferential disruption of prefrontal GABAergic function by nanomolar concentrations of the alpha7nACh negative modulator kynurenic acid. J Neurosci 37(33):7921\u20137929. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0932-17.2017","journal-title":"J Neurosci"},{"issue":"3","key":"1634_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled L, El-Khodor BF, Patry M, Suarez-Farinas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V et al (2009) Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models. Neurobiol Dis 35(3):319\u2013336. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2009.05.007","journal-title":"Neurobiol Dis"},{"issue":"5","key":"1634_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1742-481X.2009.00622.x","volume":"6","author":"J Berlanga-Acosta","year":"2009","unstructured":"Berlanga-Acosta J, Gavilondo-Cowley J, Lopez-Saura P, Gonzalez-Lopez T, Castro-Santana MD, Lopez-Mola E, Guillen-Nieto G, Herrera-Martinez L (2009) Epidermal growth factor in clinical practice\u2014a review of its biological actions, clinical indications and safety implications. Int Wound J 6(5):331\u2013346. \n                    https:\/\/doi.org\/10.1111\/j.1742-481X.2009.00622.x","journal-title":"Int Wound J"},{"issue":"3","key":"1634_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","volume":"46","author":"X Gu","year":"2005","unstructured":"Gu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S et al (2005) Pathological cell-cell interactions elicited by a neuropathogenic form of mutant huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46(3):433\u2013444. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2005.03.025","journal-title":"Neuron"},{"key":"1634_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nbd.2013.10.002","volume":"62","author":"SE Dougherty","year":"2014","unstructured":"Dougherty SE, Hollimon JJ, McMeekin LJ, Bohannon AS, West AB, Lesort M, Hablitz JJ, Cowell RM (2014) Hyperactivity and cortical disinhibition in mice with restricted expression of mutant huntingtin to parvalbumin-positive cells. Neurobiol Dis 62:160\u2013171. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2013.10.002","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1634_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","volume":"157","author":"J Spampanato","year":"2008","unstructured":"Spampanato J, Gu X, Yang XW, Mody I (2008) Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington\u2019s disease. Neuroscience 157(3):606\u2013620. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2008.09.020","journal-title":"Neuroscience"},{"issue":"7","key":"1634_CR33","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","volume":"23","author":"NH Skotte","year":"2018","unstructured":"Skotte NH, Andersen JV, Santos A, Aldana BI, Willert CW, Norremolle A, Waagepetersen HS, Nielsen ML (2018) Integrative characterization of the R6\/2 mouse model of Huntington\u2019s disease reveals dysfunctional astrocyte metabolism. Cell Rep 23(7):2211\u20132224. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2018.04.052","journal-title":"Cell Rep"},{"issue":"1","key":"1634_CR34","doi-asserted-by":"publisher","first-page":"e0191794","DOI":"10.1371\/journal.pone.0191794","volume":"13","author":"J Qi","year":"2018","unstructured":"Qi J, Kim M, Sanchez R, Ziaee SM, Kohtz JD, Koh S (2018) Enhanced susceptibility to stress and seizures in GAD65 deficient mice. PLoS One 13(1):e0191794. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0191794","journal-title":"PLoS One"},{"issue":"6","key":"1634_CR35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1046\/j.1471-4159.2003.01916.x","volume":"86","author":"I Gourfinkel-An","year":"2003","unstructured":"Gourfinkel-An I, Parain K, Hartmann A, Mangiarini L, Brice A, Bates G, Hirsch EC (2003) Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6\/2 transgenic mice. J Neurochem 86(6):1369\u20131378","journal-title":"J Neurochem"},{"issue":"36","key":"1634_CR36","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.1523\/JNEUROSCI.2804-08.2008","volume":"28","author":"AG Walker","year":"2008","unstructured":"Walker AG, Miller BR, Fritsch JN, Barton SJ, Rebec GV (2008) Altered information processing in the prefrontal cortex of Huntington\u2019s disease mouse models. J Neurosci 28(36):8973\u20138982. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2804-08.2008","journal-title":"J Neurosci"},{"issue":"4","key":"1634_CR37","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1476-5381.1993.tb13520.x","volume":"108","author":"LJ Bristow","year":"1993","unstructured":"Bristow LJ, Hutson PH, Thorn L, Tricklebank MD (1993) The glycine\/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br J Pharmacol 108(4):1156\u20131163","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1634_CR38","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/sj.npp.1300127","volume":"28","author":"R Takahata","year":"2003","unstructured":"Takahata R, Moghaddam B (2003) Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology 28(6):1117\u20131124. \n                    https:\/\/doi.org\/10.1038\/sj.npp.1300127","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"1634_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0006-8993(94)90901-6","volume":"642","author":"JD Sokolowski","year":"1994","unstructured":"Sokolowski JD, Salamone JD (1994) Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat. Brain Res 642(1\u20132):20\u201328","journal-title":"Brain Res"},{"issue":"1\u20132","key":"1634_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0006-8993(97)00810-X","volume":"772","author":"AL Jinks","year":"1997","unstructured":"Jinks AL, McGregor IS (1997) Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res 772(1\u20132):181\u2013190","journal-title":"Brain Res"},{"issue":"1","key":"1634_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s002130050649","volume":"138","author":"JD Jentsch","year":"1998","unstructured":"Jentsch JD, Tran A, Taylor JR, Roth RH (1998) Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology 138(1):89\u201395","journal-title":"Psychopharmacology"},{"issue":"2","key":"1634_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagace M, Kuan WL, Saint-Pierre M, Dury RJ, Alata W et al (2015) Cerebrovascular and blood-brain barrier impairments in Huntington's disease: potential implications for its pathophysiology. Ann Neurol 78(2):160\u2013177. \n                    https:\/\/doi.org\/10.1002\/ana.24406","journal-title":"Ann Neurol"},{"issue":"7","key":"1634_CR43","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.celrep.2017.04.021","volume":"19","author":"RG Lim","year":"2017","unstructured":"Lim RG, Quan C, Reyes-Ortiz AM, Lutz SE, Kedaigle AJ, Gipson TA, Wu J, Vatine GD et al (2017) Huntington\u2019s disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits. Cell Rep 19(7):1365\u20131377. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2017.04.021","journal-title":"Cell Rep"},{"issue":"12","key":"1634_CR44","doi-asserted-by":"publisher","first-page":"180165","DOI":"10.1098\/rsob.180165","volume":"8","author":"YT Hsu","year":"2018","unstructured":"Hsu YT, Chang YG, Chern Y (2018) Insights into GABAAergic system alteration in Huntington\u2019s disease. Open Biol 8(12):180165. \n                    https:\/\/doi.org\/10.1098\/rsob.180165","journal-title":"Open Biol"},{"key":"1634_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbr.2015.09.030","volume":"296","author":"AL Philpott","year":"2016","unstructured":"Philpott AL, Cummins TDR, Bailey NW, Churchyard A, Fitzgerald PB, Georgiou-Karistianis N (2016) Cortical inhibitory deficits in premanifest and early Huntington\u2019s disease. Behav Brain Res 296:311\u2013317. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2015.09.030","journal-title":"Behav Brain Res"},{"issue":"33","key":"1634_CR46","doi-asserted-by":"publisher","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","volume":"29","author":"DM Cummings","year":"2009","unstructured":"Cummings DM, Andre VM, Uzgil BO, Gee SM, Fisher YE, Cepeda C, Levine MS (2009) Alterations in cortical excitation and inhibition in genetic mouse models of Huntington\u2019s disease. J Neurosci 29(33):10371\u201310386. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1592-09.2009","journal-title":"J Neurosci"},{"issue":"3","key":"1634_CR47","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0022-510X(80)90103-3","volume":"48","author":"EG Spokes","year":"1980","unstructured":"Spokes EG, Garrett NJ, Rossor MN, Iversen LL (1980) Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington\u2019s chorea subjects. J Neurol Sci 48(3):303\u2013313","journal-title":"J Neurol Sci"},{"issue":"7","key":"1634_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJM197302152880703","volume":"288","author":"TL Perry","year":"1973","unstructured":"Perry TL, Hansen S, Kloster M (1973) Huntington\u2019s chorea. Deficiency of gamma-aminobutyric acid in brain. N Engl J Med 288(7):337\u2013342. \n                    https:\/\/doi.org\/10.1056\/NEJM197302152880703","journal-title":"N Engl J Med"},{"issue":"10","key":"1634_CR49","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1056\/NEJM199009063231014","volume":"323","author":"GP Reynolds","year":"1990","unstructured":"Reynolds GP, Pearson SJ (1990) Brain GABA levels in asymptomatic Huntington\u2019s disease. N Engl J Med 323(10):682\u2013683. \n                    https:\/\/doi.org\/10.1056\/NEJM199009063231014","journal-title":"N Engl J Med"},{"issue":"2","key":"1634_CR50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0304-3940(87)90639-2","volume":"78","author":"GP Reynolds","year":"1987","unstructured":"Reynolds GP, Pearson SJ (1987) Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain. Neurosci Lett 78(2):233\u2013238","journal-title":"Neurosci Lett"},{"key":"1634_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2013.00004","volume":"7","author":"Y Iwakura","year":"2013","unstructured":"Iwakura Y, Nawa H (2013) ErbB1-4-dependent EGF\/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson\u2019s disease. Front Cell Neurosci 7:4. \n                    https:\/\/doi.org\/10.3389\/fncel.2013.00004","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"1634_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/cercor\/bhq150","volume":"21","author":"C Sanchez-Huertas","year":"2011","unstructured":"Sanchez-Huertas C, Rico B (2011) CREB-dependent regulation of GAD65 transcription by BDNF\/TrkB in cortical interneurons. Cereb Cortex 21(4):777\u2013788. \n                    https:\/\/doi.org\/10.1093\/cercor\/bhq150","journal-title":"Cereb Cortex"},{"issue":"2","key":"1634_CR53","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s12035-015-9633-0","volume":"54","author":"CC Chou","year":"2017","unstructured":"Chou CC, Modi JP, Wang CY, Hsu PC, Lee YH, Huang KF, Wang AH, Nan C et al (2017) Activation of brain L-glutamate decarboxylase 65 isoform (GAD65) by phosphorylation at threonine 95 (T95). Mol Neurobiol 54(2):866\u2013873. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9633-0","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1634_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1042\/BJ20110679","volume":"442","author":"DB Rush","year":"2012","unstructured":"Rush DB, Leon RT, McCollum MH, Treu RW, Wei J (2012) Palmitoylation and trafficking of GAD65 are impaired in a cellular model of Huntington\u2019s disease. Biochem J 442(1):39\u201348. \n                    https:\/\/doi.org\/10.1042\/BJ20110679","journal-title":"Biochem J"},{"issue":"7","key":"1634_CR55","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nn.2346","volume":"12","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, You YM, Pollema SL, Kaminska A, Liu K, Yoshioka K, Bjorkblom B, Coffey ET et al (2009) Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci 12(7):864\u2013871. \n                    https:\/\/doi.org\/10.1038\/nn.2346","journal-title":"Nat Neurosci"},{"issue":"2","key":"1634_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00018-004-4339-x","volume":"62","author":"M Song","year":"2005","unstructured":"Song M, Messing RO (2005) Protein kinase C regulation of GABAA receptors. Cell Mol Life Sci 62(2):119\u2013127. \n                    https:\/\/doi.org\/10.1007\/s00018-004-4339-x","journal-title":"Cell Mol Life Sci"},{"issue":"13","key":"1634_CR57","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/neu.20327","volume":"66","author":"CL Bell-Horner","year":"2006","unstructured":"Bell-Horner CL, Dohi A, Nguyen Q, Dillon GH, Singh M (2006) ERK\/MAPK pathway regulates GABAA receptors. J Neurobiol 66(13):1467\u20131474. \n                    https:\/\/doi.org\/10.1002\/neu.20327","journal-title":"J Neurobiol"},{"issue":"41","key":"1634_CR58","doi-asserted-by":"publisher","first-page":"ra9","DOI":"10.1126\/scisignal.1162396","volume":"1","author":"IV Lund","year":"2008","unstructured":"Lund IV, Hu Y, Raol YH, Benham RS, Faris R, Russek SJ, Brooks-Kayal AR (2008) BDNF selectively regulates GABAA receptor transcription by activation of the JAK\/STAT pathway. Sci Signal 1(41):ra9. \n                    https:\/\/doi.org\/10.1126\/scisignal.1162396","journal-title":"Sci Signal"},{"issue":"17","key":"1634_CR59","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1523\/JNEUROSCI.23-17-06956.2003","volume":"23","author":"SH Li","year":"2003","unstructured":"Li SH, Yu ZX, Li CL, Nguyen HP, Zhou YX, Deng C, Li XJ (2003) Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J Neurosci 23(17):6956\u20136964","journal-title":"J Neurosci"},{"issue":"5","key":"1634_CR60","doi-asserted-by":"publisher","first-page":"e64037","DOI":"10.1371\/journal.pone.0064037","volume":"8","author":"C Giampa","year":"2013","unstructured":"Giampa C, Montagna E, Dato C, Melone MA, Bernardi G, Fusco FR (2013) Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington\u2019s disease. PLoS One 8(5):e64037. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0064037","journal-title":"PLoS One"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1634-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1634-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T13:52:30Z","timestamp":1589896350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1634-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,19]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1634"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1634-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,19]]},"assertion":[{"value":"6 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"All procedures follow the UIC Institutional Animal Care and Use Committee protocols.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}